Drug interactions
Ropeginterferon alfa 2b + Ruxolitinib
Severity: Moderate
Ropeginterferon alfa 2b and Ruxolitinib: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both drugs can suppress bone marrow function, so combined use may cause additive anemia, neutropenia and thrombocytopenia. They are sometimes used sequentially in myeloproliferative disease but together require care.
What this interaction means in plain words
Ropeginterferon alfa 2b and Ruxolitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive pharmacodynamic myelosuppression.
What to do
Monitor complete blood counts regularly and reduce or interrupt either drug if significant cytopenias develop.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ropeginterferon alfa 2b and Ruxolitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Ruxolitinib
Frequently asked questions
Can I take Ropeginterferon alfa 2b with Ruxolitinib?
MediHelp rates the interaction as moderate. Ropeginterferon alfa 2b and Ruxolitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can suppress bone marrow function, so combined use may cause additive anemia, neutropenia and thrombocytopenia. They are sometimes used sequentially in myeloproliferative disease but together require care.
How serious is the interaction between Ropeginterferon alfa 2b and Ruxolitinib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts regularly and reduce or interrupt either drug if significant cytopenias develop.
What other medicines interact with Ruxolitinib?
MediHelp also lists interactions of Ruxolitinib with, for example, Atazanavir, Ceritinib, Chloramphenicol. The full list is on the Ruxolitinib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
